Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine

被引:0
|
作者
Akira Hata
Yoshihiro Onouchi
机构
[1] Graduate School of Medicine,Department of Public Health
[2] Chiba University,undefined
[3] Laboratory for Cardiovascular Diseases,undefined
[4] Center for Genomic Medicine,undefined
来源
Journal of Human Genetics | 2009年 / 54卷
关键词
coronary artery legions; inositol 1,4,5-trisphosphate 3-kinase C; Kawasaki's disease; personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
Kawasaki disease (KD) is an acute systemic vasculitis syndrome, which primarily affects in children under the age of 5 years. In 20–25% of cases, if untreated, coronary artery lesions develop, making KD the leading cause of acquired heart disease in children in both Japan and the United States. Since 1970, 19 nationwide surveys of KD in Japan have been conducted every 2 years and the data are stored in a database. Even though the etiology of KD remains unknown, despite enthusiastic research spanning more than 40 years, we have learnt a great deal about KD from this enormous database. These 19 epidemiologic studies indicate a strong genetic influence on the disease susceptibility, prompting us and other researchers to identify the responsible genes for KD by applying either the candidate gene approach or the genome-wide approach. We have employed a genome-wide linkage study using affected sibling pair data of KD in Japan and have identified several susceptibility loci. Further analysis focusing on a region of chromosome 19, where one of the linked loci was detected, identified a predisposing gene, which codes inositol 1,4,5-trisphosphate 3-kinase C (ITPKC). In this review, we summarize the cumulative knowledge regarding KD, and then outline our hypothesis of the role ITPKC plays in KD susceptibility and our trial that aims toward the implementation of personalized medicine for KD.
引用
收藏
页码:67 / 73
页数:6
相关论文
共 50 条
  • [21] Toward identification of susceptibility genes for sporadic Parkinson's disease
    Toda, T
    Momose, Y
    Murata, M
    Tamiya, G
    Yamamoto, M
    Hattori, N
    Inoko, H
    JOURNAL OF NEUROLOGY, 2003, 250 : 40 - 43
  • [22] Toward personalized medicine for cardiovascular pharmacotherapy
    Tamargo, Juan
    Hasegawa, Koji
    Agewall, Stefan
    EUROPEAN HEART JOURNAL, 2022, 43 (45) : 4719 - 4721
  • [23] Progress toward personalized medicine for glaucoma
    Moroi, Sayoko E.
    Raoof, Duna A.
    Reed, David M.
    Zoellner, Sebastian
    Qin, Zhaohui
    Richards, Julia E.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (02) : 145 - 161
  • [24] Skipping toward personalized molecular medicine
    Hoffman, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26): : 2719 - 2722
  • [25] Toward identification of susceptibility genes for sporadic Parkinson’s disease
    Tatsushi Toda
    Yoshio Momose
    Miho Murata
    Gen Tamiya
    Mitsutoshi Yamamoto
    Nobutaka Hattori
    Hidetoshi Inoko
    Journal of Neurology, 2003, 250 : iii40 - iii43
  • [26] Toward Personalized Medicine in Renal Transplantation
    Lampreabe, I.
    Gainza de Los Rios, F. J.
    Arrieta Gutierrez, A.
    Jofre-Monseny, L.
    Rodriguez, M.
    Amenabar Iribar, J. J.
    Zarraga Larrondo, S.
    Tejedor, D.
    Martinez, A.
    Olano-Martin, E.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 2864 - 2867
  • [27] TOWARD PERSONALIZED MEDICINE IN THE NEUROPSYCHIATRIC FIELD
    Wong, Erik H. F.
    Fox, Jayne C.
    Ng, Mandy Y. M.
    Lee, Chi-Ming
    BIOMARKERS OF NEUROLOGICAL AND PSYCHIATRIC DISEASE, 2011, 101 : 329 - 349
  • [28] From bioinformatics toward personalized medicine
    Fukuoka Y.
    Transactions of Japanese Society for Medical and Biological Engineering, 2019, 57 (4-5): : 99 - 104
  • [29] Precision medicine, Two steps toward personalized medicine
    Garcia, Heathcliff Dorado
    NATURE CANCER, 2024, 5 (12) : 1784 - 1784
  • [30] Great challenges in molecular medicine: toward personalized medicine
    Katoh, Masaru
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2013, 1